Singularity Future Technology Ltd

This proposal requests shareholder authorization to issue 21,520,803 shares in a private placement under an August 12, 2026 securities purchase agreement at $1.394 per share for gross proceeds of approximately $30 million. Management is seeking approval because closing of the financing is conditioned on shareholder ratification and certain investor representations require this approval under the transaction documents. The proxy discloses customary SPA representations and closing conditions, and incorporates the full form of the SPA by reference, which will govern investors’ rights and post-closing matters. The issuance will materially increase outstanding shares and dilute existing holders, but provides immediate capital intended to fund the company’s business plan (including construction and development of an AI/supercomputing center per the SPA use of proceeds). The Board recommends a FOR vote, arguing the financing is commercially beneficial and necessary for operations and growth. Key governance considerations include whether the issuance terms (price, registration/exemption mechanics, transfer restrictions) and investor protections (legends, resale limitations) are appropriate and whether the shareholder approval sufficiently safeguards minority holders. An analyst should evaluate the dilution versus runway and strategic benefits, review Appendix A for detailed covenants, anti-dilution provisions and investor rights, and consider potential resale constraints (Regulation S/non-U.S. purchasers) that could affect liquidity of new shares.

This proposal asks shareholders to approve an amendment that would replace previously issued warrants with Amended Warrants exercisable for one share at $0.001, substantially lowering the original exercise price. Management requires shareholder approval because the Amendment materially affects the economic terms of previously negotiated investor instruments and the SPA conditions make approval non-waivable. The Amended Warrants are immediately exercisable for cash at $0.001 or via a cashless mechanism if resale registration is not available, and they expire five years after issuance; they also contain customary anti-dilution protections. The economic effect is to potentially transfer substantial value to warrant holders upon exercise, creating significant dilution for existing shareholders, but it may be necessary to preserve investor relationships or enable capitalization events tied to the 2025 financing. Key governance issues include whether the company obtains fair economic consideration for lowering exercise prices, potential preferential treatment of certain investors, and the impact on public float and future capital raising. Analysts should review Appendix B and C to assess conversion mechanics, anti-dilution provisions, registration rights, and restrictions on resale (Regulation S/non-U.S. purchasers). The Board’s recommendation for approval reflects its judgment that the amendment is necessary to consummate or preserve the prior transaction economics and investor commitments and to support the company’s financing strategy, but shareholders should weigh dilution vs. the strategic or contractual necessity of the amendment.

The board proposes a straightforward change of the company’s corporate name to “Compower Ltd.” to better reflect the company’s evolving business focus and commercial strategy. Management frames the name change as a branding alignment that will not affect the company’s Nasdaq listing or trading symbol. Shareholder approval is required to amend the Amended and Restated Articles of Incorporation; the Board will file the Articles of Amendment with the Virginia State Corporation Commission if approved, with timing at its discretion. From a governance perspective, name changes rarely affect substantive shareholder rights, but they can signal a strategic pivot or rebranding that may accompany business model or operational changes; investors should watch for accompanying strategic updates or shifts in disclosures. The Board’s recommendation indicates it views the change as commercially beneficial; absent other material changes, shareholder impact is primarily cosmetic. Analysts should note whether the name change coincides with operational shifts, new product lines, or M&A strategy in subsequent filings and investor communications.

This proposal seeks shareholder authorization to grant the Board flexible authority to effect, at its discretion within one year, a reverse stock split at a ratio of 1-for-5, 1-for-10, or 1-for-20 and to round up fractional shares to the next whole share. Management frames the amendment primarily as a tool to cure non-compliance with Nasdaq Listing Rule 5550(a)(2) (minimum $1.00 bid price) and to improve marketability and appeal to institutional and broker-dealer investor bases; the Board emphasizes that it will implement the split only if it determines it is in shareholders’ best interests. The proposal provides the Board with discretion over the exact ratio and timing, enabling responsive action based on market conditions, but this discretion can also be used to delay or abandon the split if circumstances change. Potential benefits include increasing per-share price to satisfy Nasdaq, attracting new investors, and lowering per-share transaction costs for some holders; potential downsides include reduced liquidity, increased odd-lot holdings, possible negative investor perception, and no guarantee of sustained price improvement. The rounding-up of fractional shares favors small holders by eliminating cash-in-lieu for fractions, but increases dilution slightly. Analysts should evaluate likelihood of Nasdaq delisting risk, trading liquidity, potential anti-takeover effects from increased authorized-but-unissued shares, and the Board’s historical willingness to act on similar measures. The Board’s recommendation for FOR reflects its view that the reverse split is an appropriate tool to preserve listing and improve marketability, but shareholders should weigh uncertain market reaction and dilution/odd-lot consequences.